Sara Marsal obtained a degree in medicine and surgery at the Universidad de Navarra, Spain, in 1985, and the Ph.D. degree in medicine and surgery, Universitat de Barcelona, Spain, in 1990. She joined as an Internal Resident in rheumatology the Hospital Universitari Vall d’Hebron, Barcelona, Spain (1991-1994), where she serves now as a Senior Consultant in rheumatology. She preformed a postdoctoral position at the Molecular Immunogenetics Laboratory, Guy’s Hospital, London, UK, under the direction of Professor Gabriel Panayi. Currently, she works as the Head of the Rheumatology Research Group (GRR) at the Fundació Institut de Recerca Hospital Universitari Vall d’Hebron (Barcelona, Spain). Her research is mainly focused in the genomics research in chronic inflammatory arthritis and other immune-mediated inflammatory diseases, and its application to translational research. Her areas of research include genome-wide association analyses (i.e., main effect and gene-gene interactions), gene expression microarray characterization of IMID mechanisms, and building of predictors of therapeutic response. Her group has leaded the first genome-wide association analysis in the Spanish population and one of the first studies worldwide to investigate the presence of epistatic susceptibility on a genome-wide scale. She serves now as the Director of the IMID-Kit project, a collaboration of 53 clinical departments from around Spain in which more than 13,000 samples of IMID patients are being collected and stored in a specialized biobank (IMID BioBank) which she directs. The objective of this macrostudy is the identification of relevant biomarkers for the diagnosis and prognosis of IMID diseases.
Biography Updated on 18 January 2011